Logo del repository
  1. Home
 
Opzioni

Clinical and therapeutic aspects of candidemia: A five year single centre study

BASSETTI, MATTEO
•
Merelli, Maria
•
Ansaldi, Filippo
altro
Righi, Elda
2015
  • journal article

Periodico
PLOS ONE
Abstract
B ackground Candida is an important cause of bloodstream infections (BSI) in nosocomial settings causing significant mortality and morbidity. This study was performed to evaluate contemporary epidemiology, species distribution, antifungal susceptibility and outcome of candida BSI in an Italian hospital. Methods All consecutive patients who developed candidemia at Santa Maria della Misericordia University Hospital (Italy) between January 2009 and June 2014 were enrolled in the study. Results A total of 204 episodes of candidemia were identified during the study period with an incidence of 0.79 episodes/1000 admissions. C. albicans was isolated in 60.3% of cases, followed by C. parapsilosis (16.7%), C. glabrata (11.8%) and C. tropicalis (6.4%). Of all Candida BSI, 124 (60.8 %) occurred in patients admitted to IMW, 31/204 (15.2 %) in ICUs, 33/204 (16.2%) in surgical units and 16/204 (7.8%) in Hematology/Oncology wards. Overall, 47% of patients died within 30 days from the onset of candidemia. C. parapsilosis and C. glabrata candidemia were associated with the lowest mortality rate (36%), while patients with C. tropicalis BSI had the highest mortality rate (58.3%). Lower mortality rates were detected in patients receiving therapy within 48 hours from the time of execution of the blood cultures (57,1% vs 38,9%, P <0.05). At multivariate analysis, steroids treatment (OR= 0.27, p=0.005) and CVC removal (OR=3.77, p=0.014) were independently associated with lower and higher survival probability, respectively. Candidemia in patients with peripherally inserted central catheters (PICC) showed to be associated with higher mortality in comparison with central venous catheters (CVC, Short catheters and Portacath) and no CVC use. For each point increase of APACHE III score, survival probability decreased of 2%. Caspofungin (OR=3.45, p=0.015) and Amphothericin B lipid formulation (OR=15.26, p=0.033) were independently associated with higher survival probability compared with no treatment.
DOI
10.1371/journal.pone.0127534
WOS
WOS:000355183900106
Archivio
http://hdl.handle.net/11390/1100998
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84960115849
http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0127534&representation=PDF
Diritti
open access
Soggetti
  • Aged

  • Aged, 80 and over

  • Antifungal Agent

  • Candida

  • Candidemia

  • Female

  • Human

  • Male

  • Microbial Sensitivity...

  • Middle Aged

  • Multivariate Analysi

  • Patients' Room

  • Risk Factor

  • Survivor

  • Medicine (all)

  • Biochemistry, Genetic...

  • Agricultural and Biol...

Scopus© citazioni
78
Data di acquisizione
Jun 14, 2022
Vedi dettagli
Web of Science© citazioni
84
Data di acquisizione
Mar 27, 2024
google-scholar
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your nstitution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Realizzato con Software DSpace-CRIS - Estensione mantenuta e ottimizzata da 4Science

  • Impostazioni dei cookie
  • Informativa sulla privacy
  • Accordo con l'utente finale
  • Invia il tuo Feedback